Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Sep;19(3):273-8.
doi: 10.4103/0971-6580.103668.

A-90 Day Gavage Safety Assessment of Boswellia Serrata in Rats

Free PMC article

A-90 Day Gavage Safety Assessment of Boswellia Serrata in Rats

Pooja Singh et al. Toxicol Int. .
Free PMC article


The present study deals with the evaluation and assessment of the safety/toxic potential of Boswellia serrata, a well known Ayurvedic herb used to treat disorders of digestive system, respiratory ailments and bone related diseases. A repeated dose oral (90 days) toxicity study of Boswellia serrata was carried out. For this, 10 rats of each sex were treated with the Boswellia serrata at three different doses i.e. 100, 500 and 1000 mg/kg B. wt. /day. As a control, 10 rats of each sex were treated with corn oil only which was the vehicle. Two groups consisting of five male and five female rats were kept as control recovery and high dose recovery group which were treated with the vehicle (corn oil) and the Boswellia serrata at the dose of 1000 mg/kg B. wt. Animals of control recovery and high dose recovery groups were further observed for 28 days without any treatment. From this study, it was found that the rats treated with high dose of the Boswellia serrata gained their body weight with much less rate than that of the control group. However, during the recovery period, the loss in body weight gain as observed during the study period exhibits a reversible effect on the metabolic activity and recovered. The results also indicate that Boswellia serrata is relatively safe in rat up to the dose of 500 mg/kg B.wt. as no adverse impact on health factors was observed. Thus, the No observed adverse effect level is 500 mg/kg B. wt.

Keywords: Boswellia serrata; NOAEL; safety; sub-chronic; toxicity; wistar rat.

Conflict of interest statement

Conflict of Interest: None declared.

Similar articles

See all similar articles

Cited by 7 articles

See all "Cited by" articles


    1. Alternative Medicine Review. 2008;13(number 2)
    1. Singh GB, Atal CK. Pharmacology of an extract of Salai guggal ex-Boswellia serrata, A new non steroidal anti-inflammatory agent. Agents Actions. 1986;18:407–12. - PubMed
    1. Sharma ML, Bani S, Singh GB. Anti-arthritic activity of boswellic acids in bovine serum albumin (BSA)-induced arthritis. Int J Immunopharmacol. 1989;11:647–52. - PubMed
    1. Gupta I, Parihar A, Malhotra P, Gupta S, Ludtke A, Safayhi H, et al. Effects of gum resin of Boswellia serrata in patients with chronic colitis. Planta Med. 2001;67:391–5. - PubMed
    1. Gupta I, Gupta V, Parihar A, Gupta S, Ludtke R, Safayhi H, et al. Effects of Boswellia serrata gum resin in patients with bronchial asthma: Results of a double-blind, placebo controlled, 6-week clinical study. Eur J Med Res. 1998;3:511–4. - PubMed